Potential of osteopontin in the management of epithelial ovarian cancer
, , , e
31 gen 2019
INFORMAZIONI SU QUESTO ARTICOLO
Categoria dell'articolo: Research Article
Pubblicato online: 31 gen 2019
Pagine: 105 - 115
Ricevuto: 07 set 2018
Accettato: 27 dic 2018
DOI: https://doi.org/10.2478/raon-2019-0003
Parole chiave
© 2019 Katarina Cerne, Benjamin Hadzialjevic, Erik Skof, Ivan Verdenik, Borut Kobal published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
Cerne, Katarina
Institute of Pharmacology and Experimental Toxicology, Faculty of Medicine, University LjubljanaLjubljana, Slovenia
Hadzialjevic, Benjamin
Institute of Pharmacology and Experimental Toxicology, Faculty of Medicine, University LjubljanaLjubljana, Slovenia
Skof, Erik
Department of Medical Oncology, Institute of Oncology LjubljanaLjubljana, Slovenia
Verdenik, Ivan
Department of Gynaecology, Division of Gynaecology and Obstetrics, University Medical Centre LjubljanaLjubljana, Slovenia
Department of Gynaecology and Obstetrics, Faculty of Medicine, University LjubljanaLjubljana, Slovenia
Kobal, Borut
Department of Gynaecology, Division of Gynaecology and Obstetrics, University Medical Centre LjubljanaLjubljana, Slovenia
Department of Gynaecology and Obstetrics, Faculty of Medicine, University LjubljanaLjubljana, Slovenia